Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer

Pathology and Oncology Research

Volumn 15, Issue 4, 2009, Pages 555-560

  Ren, Tingting ^a,c   Jiang, Beihai ^a   Xing, Xiaofang ^a   Dong, Bin ^b   Peng, Lirong ^a   Meng, Lin ^a   Xu, Huiyu ^a   Shou, Chengchao ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b CANCER HOSPITAL   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Expression; Immunohistochemistry; Ovarian cancer; PRL 3; Prognosis

Indexed keywords

PROTEIN PRL 3; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PROGNOSIS; PROTEIN EXPRESSION; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASES; TUMOR MARKERS, BIOLOGICAL;

EID: 75049085070     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9153-1     Document Type: Article

References (25)

1. SA Cannistra 2004 Cancer of the ovary N Engl J Med 351 2519 2529 10.1056/NEJMra041842 1:CAS:528:DC%2BD2cXhtVGksbbM 15590954 (Pubitemid 39603165)
2. VR Zurawski Jr H Orjaseter A Andersen, et al. 1988 Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer Int J Cancer 42 677 680 10.1002/ijc.2910420507 3182103 (Pubitemid 19008906)
3. W Mastropaolo Z Fernandez EL Miller 1986 Pronounced increases in the concentration of an ovarian tumor marker, CA-125, in serum of a healthy subject during menstruation Clin Chem 32 2110 2111 1:CAS:528:DyaL2sXjtVyisg%3D%3D 3465487
4. K Takahashi T Shibukawa M Moriyama 1986 Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer-a study on 674 patients Jpn J Surg 16 305 310 10.1007/BF02470551 1:STN:280: DyaL2s%2FoslGltQ%3D%3D 3467109
5. M Lyon A Ducruet P Wipf, et al. 2002 Dual-specificity phosphates as targets for antineoplastic agents Nat Rev Drug Discov 1 961 976 10.1038/nrd963 1:CAS:528:DC%2BD38XptFKmsLw%3D 12461518 (Pubitemid 37361602)
6. Q Zeng W Hong YH Tan 1998 Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1 Biochem Biophys Res Commun 244 421 427 10.1006/bbrc.1998.8291 1:CAS:528:DyaK1cXitVKrs7w%3D 9514946 (Pubitemid 28414098)
7. RH Diamond DE Cressman TM Laz, et al. 1994 PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth Mol Cell Biol 14 3752 3762 1:CAS:528:DyaK2cXlslemsLk%3D 8196618
8. SR Werner PA Lee MW DeCamp, et al. 2003 Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases Cancer Lett 202 201 211 10.1016/S0304-3835(03)00517-2 1:CAS:528:DC%2BD3sXpt1eksrc%3D 14643450 (Pubitemid 37485893)
9. F Polato A Codegoni R Fruscio, et al. 2005 PRL-3 phosphatase is implicated in ovarian cancer growth Clin Cancer Res 11 6835 6839 10.1158/1078-0432.CCR-04-2357 1:CAS:528:DC%2BD2MXhtVKiur3E 16203771 (Pubitemid 41430477)
10. Q Zeng JM Dong K Guo, et al. 2003 PRL-3 and PRL-1 promote cell migration, invasion, and metastasis Cancer Res 63 2716 2722 1:CAS:528:DC%2BD3sXkvFartr4%3D 12782572
11. X Wu H Zeng X Zhang 2004 Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells Am J Pathol 23 23 27
12. K Guo J Li JP Tang, et al. 2004 Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels Cancer Biol Ther 3 945 951 1:CAS:528:DC%2BD2MXjtFSqt7w%3D 15326366
13. J Li K Guo VW Koh, et al. 2005 Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases Clin Cancer Res 11 2195 2204 10.1158/1078-0432.CCR-04-1984 1:CAS:528: DC%2BD2MXisFajuro%3D 15788667 (Pubitemid 40490178)
14. Guo K, Li J, Tang JP, et al (2008) Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice. Cancer Biol Ther 7
15. L Peng Y Li L Meng, et al. 2004 Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3 Hybrid Hybridomics 23 23 27 10.1089/153685904322771999 1:CAS:528:DC%2BD2cXhtF2qtL4%3D 15000845 (Pubitemid 38241551)
16. L Peng J Ning L Meng, et al. 2004 The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer J Cancer Res Clin Oncol 130 521 526 10.1007/s00432-004-0563-x 1:CAS:528:DC%2BD2cXmt1Krtb8%3D 15133662
17. L Wang L Peng B Dong, et al. 2006 Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome Ann Oncol 17 1517 1522 10.1093/annonc/mdl159 1:STN:280:DC%2BD28rnsFyksA%3D%3D 16873432 (Pubitemid 44542037)
18. Y Wang ZF Li J He, et al. 2007 Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis Int J Colorectal Dis 22 1179 1184 10.1007/s00384-007-0303- 1 17440740 (Pubitemid 47304786)
19. UA Miskad S Semba H Kato H Yokozaki 2004 Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis Pathobiology 71 176 184 10.1159/000078671 1:CAS:528:DC%2BD2cXlsl2qtr4%3D 15263806 (Pubitemid 38969875)
20. UA Miskad S Semba H Kato, et al. 2007 High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study Virchows Arch 450 303 310 10.1007/s00428-006-0361-8 1:CAS:528:DC%2BD2sXis1Kgsr4%3D 17235563 (Pubitemid 46376561)
21. B Stephens H Han V Gokhale, et al. 2005 PRL phosphatases as potential molecular targets in cancer Mol Cancer Ther 4 1653 1661 10.1158/1535-7163.MCT- 05-0248 1:CAS:528:DC%2BD2MXhtFyrtLvP 16275986 (Pubitemid 41685299)
22. H Han DJ Bearss LW Browne, et al. 2002 Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray Cancer Res 62 2890 2896 1:CAS:528:DC%2BD38XjvFSmt7c%3D 12019169
23. B Stephens H Han G Hostetter, et al. 2008 Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells Mol Cancer Ther 7 202 210 10.1158/1535-7163.MCT-07-0542 1:CAS:528:DC%2BD1cXmsVygsA%3D%3D 18187808
24. H Kato S Semba UA Miskad, et al. 2004 High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases Clin Cancer Res 10 7318 7328 10.1158/1078-0432.CCR-04-0485 1:CAS:528: DC%2BD2cXpsVKlurY%3D 15534108 (Pubitemid 39487721)
25. I Radke M Gotte C Kersting, et al. 2006 Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer Br J Cancer 95 347 354 10.1038/sj.bjc.6603261 1:CAS:528:DC%2BD28Xnsl2hsrs%3D 16832410 (Pubitemid 44187596)